fbpx

Fluoroquinolones associated with retinal detachment

Health Canada warns against the risks of retinal detachment associated with oral fluoroquinolones.

 

Five oral fluoroquinolones are available in Canada: ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, and ofloxacin. These are large-spectrum antibiotics prescribed to treat infections caused by sensitive strains of microorganisms.

 

A pharmacoepidemiological study published in 2012 in the Journal of the American Medical Association (JAMA) identified 445 cases of retinal detachment associated with oral fluoroquinolones in a cohort of 989,591 patients in British Columbia, who consulted an ophthalmologist between January 2000 and December 2007.

 

For its part, Health Canada had only a single reported incident of suspected retinal detachment associated with this type of antibiotic as of December 31, 2012. The difficulty in establishing solid evidence establishing a link between retinal detachment and fluoroquinolones could account for this low level of reported cases.

 

Health Canada invites health-care professionals to be watchful and encourages them to report any adverse reactions suspected of being associated with these antibiotics.

Featured Posts

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read More

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read More

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Learn More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

Students and Binocular Vision: The Hidden Obstacle

Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting appointments to the office.

Read more

Myopia Profile Enhances its Managing Myopia Reference Guide to Elevate Patient Care

Free Multi-Part Resource Available for Download in 10 Languages

Read more

Registration Now Open for Vision Expo East 2024

The Vision Council and RX announce that registration for Vision Expo East 2024 is officially open.

Read more